research use only

Adefovir Dipivoxil (GS 0840) Reverse Transcriptase inhibitor

Cat.No.S1718

Adefovir Dipivoxil (GS 0840) is a reverse transcriptase inhibitor used in the treatment of chronic hepatitis B virus (HBV).
Adefovir Dipivoxil (GS 0840) Reverse Transcriptase inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 501.47

Jump to

Quality Control

Batch: Purity: 99.99%
99.99

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (199.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 501.47 Formula

C20H32N5O8P

Storage (From the date of receipt)
CAS No. 142340-99-6 Download SDF Storage of Stock Solutions

Mechanism of Action

Targets/IC50/Ki
HBV RT
In vivo
Adefovir Dipivoxil (GS 0840) reduces Liver HBV DNA to <0.1 pg of viral DNA per mg of total DNA (pg/mg) in transgenic mice expressing hepatitis B virus. This compound also reduces serum HBV DNA to 3.5 log10 genomic equivalents (ge)/mL in the same model, compared to 5.3 log10 ge/mL for the placebo control group. Its antiviral activity reaches near maximum viral reduction by day 10 in the liver and achieves an endpoint of liver virus inhibition at 1.0 mg/kg/day.
References
  • [4] https://pubmed.ncbi.nlm.nih.gov/10718947/
  • [5] https://pubmed.ncbi.nlm.nih.gov/12865451/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00489151 Unknown status
Hepatitis B
Hospital Authority Hong Kong|The University of Hong Kong
June 2005 Not Applicable
NCT00644761 Completed
Hepatitis B
Gilead Sciences
February 2004 Phase 2
NCT00230477 Completed
Hepatitis B
University of Washington|Gilead Sciences|GlaxoSmithKline
April 2003 Phase 4
NCT00158717 Completed
Hepatitis B
Gilead Sciences
April 2003 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map